In short
This article explores a clinical trial investigating the use of Oxycodone Hydrochloride Trihydrate for pain relief during labor. The study aims to assess the drug's efficacy, safety, and effects on newborns, as well as to understand its pharmacokinetics in pregnant women. This research is crucial for improving pain management options for women during childbirth while ensuring the safety of both mother and baby.
At a glance
- Study Title
- The efficacy, safety and neonatal effects of oxycodone in treatment of labour pain
- Main Objective
- Measure maternal and umbilical concentrations of oxycodone soon after birth
- Secondary Objective
- Oxycodone population pharmacokinetic modeling, efficacy, and effect on the newborn
- Inclusion Criteria
- Oxycodone given for labour pain, age ≥ 18 years, informed consent given
- Exclusion Criteria
- Oxycodone not used for labour pain, age < 18 years, no informed consent
- Study Design
- Observational pharmacokinetic study
- Drug Information
- Oxanest® 10 mg/ml injection solution (Oxycodone Hydrochloride Trihydrate)
- Maximum Daily Dose
- 20 mg
- Maximum Total Dose
- 40 mg
- Administration Route
- Subcutaneous injection
What is Oxycodone Hydrochloride Trihydrate?
Oxycodone Hydrochloride Trihydrate is a powerful pain-relieving medication that belongs to a class of drugs known as opioids. It is also known by its brand name Oxanest® when formulated as a 10 mg/ml solution for injection. Oxycodone is classified under the ATC code N02AA05, which indicates its use as a pain medication.
Use in Labor Pain Management
One of the areas where oxycodone is being studied is in the management of labor pain. A clinical trial is currently underway to investigate the effectiveness and safety of oxycodone for pain relief during childbirth. This research aims to provide valuable information about how this medication can be used to help mothers manage the intense pain associated with labor.
Current Clinical Trial
A clinical trial titled "The efficacy, safety and neonatal effects of oxycodone in treatment of labour pain" is currently being conducted. This study has several important aspects:
- Main Objective: To measure the concentrations of oxycodone in the mother's blood and the umbilical cord shortly after birth. This will help researchers understand how the drug moves through the body during labor and delivery.
- Secondary Objectives: To create a model of how oxycodone behaves in the bodies of women giving birth, to assess its effectiveness for pain relief, and to study its effects on newborn babies.
- Inclusion Criteria: The study includes women who are at least 18 years old, have given informed consent, and are using oxycodone for labor pain relief.
- Exclusion Criteria: Women under 18 years old, those not using oxycodone for labor pain, or those who have not given informed consent are not included in the study.
How is it Administered?
Oxanest®, the brand name for this formulation of oxycodone, is administered as a solution for injection. It can be given through a subcutaneous injection, which means it's injected just under the skin. This method of administration allows for quick pain relief, which is particularly important during labor.
Dosage Information
According to the clinical trial information, the following dosage details are provided:
- Maximum Daily Dose: 20 mg
- Maximum Total Dose: 40 mg
- Maximum Treatment Period: 2 days
It's important to note that these dosages are specific to the clinical trial and may not reflect the typical dosing for all patients or situations. Always follow your healthcare provider's instructions regarding medication dosage.
Safety Considerations
As with any medication, safety is a crucial concern. The ongoing clinical trial is specifically designed to assess the safety of oxycodone when used for labor pain relief. This includes monitoring for any adverse effects on both the mother and the newborn. It's important to remember that opioid medications like oxycodone can have significant side effects and risks, which is why their use is carefully controlled and monitored by healthcare professionals.
Effects on Newborns
One of the key aspects of the current clinical trial is to study the effects of oxycodone on newborn babies. This includes:
- Measuring oxycodone levels in the umbilical cord blood at birth
- Observing any immediate effects on the newborn
- Monitoring for any potential short-term or long-term impacts
This research will provide valuable information about the safety of using oxycodone during labor and its potential effects on newborns. It's important for expectant mothers to discuss the risks and benefits of pain management options with their healthcare providers.